DEXCOM INC. - US2521311074 (Stock)
/IBT-BA-HP/WEB-INF/snippets/root/general/name.jsp
0
0
0
66,59 USD
|
-0,7601% |
11.04.2025 16:01
|
136,00 |
82,40 |
- |
0,00 |
/IBT-BA-HP/WEB-INF/snippets/root/general/v2/infobar.jsp
0
0
0
/IBT-BA-HP/WEB-INF/snippets/root/general/toolbar.jsp
35
0
35
/IBT-BA-HP/WEB-INF/snippets/root/stock/navigation.jsp
34
0
34
Balance ratios |
2024 |
2023 |
Total assets |
6.484.500 USD |
6.264.500 USD |
Employees |
10.300 |
9.600 |
Cash and cash equivalents |
606.100 USD |
566.300 USD |
Intangible / inalienable assets |
126.200 USD |
159.700 USD |
Economic shareholder's equity |
2.102.600 USD |
2.068.600 USD |
Subscribed Capital |
400 USD |
400 USD |
Liabilities |
4.381.900 USD |
4.195.900 USD |
Liabilities to financial institutions |
- |
- |
GuV Zahlen |
2024 |
2023 |
Sales |
4.033.000 USD |
3.622.300 USD |
Profit after tax |
576.200 USD |
541.500 USD |
Deprecation (??) |
217.700 USD |
186.000 USD |
Dividend ordinary shares |
- |
- |
Net investment income |
0 USD |
0 USD |
Dividend preferred shares |
- |
- |
Net interests income |
115.200 USD |
114.700 USD |
Earnings from ordinary operating activities |
709.000 USD |
710.400 USD |
Net income (after minority interests) |
576.200 USD |
541.500 USD |
Net earnings per share |
1.42 USD |
1.3 USD |
Total payout |
0 USD |
0 USD |
Administrative expenses |
- |
- |